We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Genomic Approach Identifies Food Pathogens

By LabMedica International staff writers
Posted on 10 Nov 2011
A molecular approach will enable government agencies and public health officials to pinpoint the exact nature and origin of food-borne bacteria with unprecedented accuracy.

The molecular technique is able to discriminate rapidly between outbreak-related cases and non-outbreak related cases by isolating pathogens believed to be connected to contaminated food. More...


A collaborative team led by scientists at Cornell University (Ithaca, NY, USA) adopted a genomic approach to identifying food-borne pathogens. They sequenced the genome of 47 samples of the bacteria, 20 that had been collected from human sources during an outbreak, and 27 control samples collected from human, food, animal and environmental sources before the outbreak.

The team developed the single nucleotide polymorphism (SNP) test that is specific to the Salmonella enterica strain that had caused a previous outbreak. The sequencing was performed on the SOLiD systems (Life Technologies, Foster City, CA). Pulsed Field Gel Electrophoresis (PFGE) was also performed. Overall, 969 SNP positions were found among the 82 isolates analyzed.

Three SNPs were found to be completely specific for the isolates associated with the outbreak clade.

This study demonstrates that massively parallel sequencing can be used to assess the population structure of highly clonal, outbreak-associated pathogens at single base resolution. Martin Wiedmann, DVM, PhD, a professor at Cornell said, "The use of genome sequencing methods to investigate outbreaks of food-borne bacterial diseases is relatively new, and holds great promise as it can help to identify the temporal, geographical and evolutionary origin of an outbreak. In particular, full genome sequence data may help to identify small outbreaks that may not be easily detected with lower resolution subtyping approaches.” The study was published online on October 14, 2011, in the journal Applied and Environmental Microbiology.

Related Links:
Cornell University
Life Technologies




Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Bacterial GI Multiplex PCR Assay
Allplex GI-Bacteria(I) plus Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Industry

view channel
Image: The partnership with LLS expands access to Lucent’s non-invasive blood-based biomarker tests for early detection of cognitive diseases (photo courtesy of Adobe Stock)

New Partnership Brings Alzheimer’s Blood Biomarker Test to Community Screening Network

Lucent Diagnostics, a brand of Quanterix Corporation, has partnered with Life Line Screening (LLS) to offer Lucent’s non‑invasive, blood‑based biomarker test across the United States. Programs are... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.